ValueBuddies.com : Value Investing Forum - Singapore, Hong Kong, U.S.

Pages (801): « Previous 1 … 616 617 618 619 620 … 801 Next »

Date & Time	Title
Tue, 10 Dec 2024 22:00:00 +0800	KPM Analytics Expands AI and Software Development Operations to Drive Innovation
Tue, 10 Dec 2024 22:00:00 +0800	Solace Unlocks Full Potential of Event-Driven Integration with Introduction of PubSub+ Micro-Integrations
Tue, 10 Dec 2024 22:00:00 +0800	Next Level Aviation® Secures $50MM Credit Facility with PNC Bank
Tue, 10 Dec 2024 22:00:00 +0800	DL E&C Marks First Entry into Canadian Blue Ammonia Market
Tue, 10 Dec 2024 22:00:00 +0800	MinIO Research Reveals the Impact of AI on Storage Infrastructure
Tue, 10 Dec 2024 22:00:00 +0800	Stamus Networks Announces Clear NDR: The Next Generation of Open and Transparent Network Defense
Tue, 10 Dec 2024 21:48:00 +0800	State Grid Kashgar Power Supply Company: Special investigation on hidden dangers of electric bicycle charging
Tue, 10 Dec 2024 21:46:00 +0800	State Grid Kashgar Power Supply Company: Successfully Passed Assessment for AC and DC Charging Pile and Combined Transformer Calibration
Tue, 10 Dec 2024 21:42:00 +0800	Global Schools Group Opens One World International Digital Campus, Pioneering Digital and Sustainable Education in Singapore
Tue, 10 Dec 2024 21:41:00 +0800	2024 Understanding China Conference Concludes Successfully: A New Path for Global Understanding of Chinese Modernization
Tue, 10 Dec 2024 21:34:00 +0800	Live from ASH 2024 \| 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminib
Tue, 10 Dec 2024 21:30:00 +0800	Live from ASH 2024 \| Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in Combinations Demonstrates Potential Clinical Benefit in Patients with Prior Exposure to Venetoclax
Tue, 10 Dec 2024 21:29:00 +0800	The new battleground for commercial card providers: Rewards and flexibility, Ascenda report reveals
Tue, 10 Dec 2024 21:27:00 +0800	Live from ASH 2024 \| First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Report
Tue, 10 Dec 2024 21:26:00 +0800	Live from ASH 2024 \| 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminib
Tue, 10 Dec 2024 21:00:00 +0800	Waters Highlights Continued Progress Towards Sustainability Commitments
Tue, 10 Dec 2024 21:00:00 +0800	Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular Care
Tue, 10 Dec 2024 21:00:00 +0800	Hohem iSteady M7, the Ultimate AI Gimbal for Mobile Filmmaking
Tue, 10 Dec 2024 21:00:00 +0800	Bring Christmas Cheer to Your Home with Yaber Projectors: Holiday Sale Now Live on Amazon
Tue, 10 Dec 2024 20:55:00 +0800	Stellantis and CATL to Invest Up to €4.1 Billion in Joint Venture for Large-Scale LFP Battery Plant in Spain

Pages (801): « Previous 1 … 616 617 618 619 620 … 801 Next »

Login
Username:
Password:	Lost Password?
	Remember me